💨 Abstract

Japanese startup Craif, spun off from Nagoya University, has raised $22 million in Series C funding to develop an AI-powered early cancer detection software using microRNA (miRNA) and urine samples. Co-founder and CEO Ryuichi Onose aims to provide a non-invasive, accessible, and effective early detection solution for health-conscious individuals.

Courtesy: techcrunch.com

Summarized by Einstein Beta 🤖